VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See
50,000 volunteers (with and without Alzheimer’s) are needed to participate in hundreds of clinical trials. People with Alzheimer’s, their families, and those who serve them
In 2012, Envivo’s experimental Alzheimer’s drugs improved cognitive function as the company won a Fierce BioTech Award. Learn about and participate in their newest Phase-2
Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down
VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’
People worry about becoming forgetful. Is it the first sign of Alzheimer’s or just the passing years? After all, forgetfulness is a normal part of aging. Check out these quick ways to tell the difference.
Creating peace, calm and a sense of control over their environment is the best gift to give a person living with Alzheimer’s. Learn all about In-Home Routines.
Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.
Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.
No spam, only news and updates.
